Three scientists win Nobel medicine prize for a light-based switch for individual brain cells

Two decades after a single-celled alga gave up a protein that could switch a brain cell on with light, the 2026 Nobel in medicine recognized the three scientists who turned that quirk of evolution into a working tool. Karl Deisseroth at Stanford, Peter Hegemann at Humboldt University of Berlin, and Georg Nagel at the University of Würzburg share the prize for what the committee called "discoveries concerning light-gated ion channels and optogenetics," according to the Nobel Assembly press release.

Optogenetics, in plain language, is the practice of putting a light-sensitive protein into a specific type of neuron and then using a beam of light to turn that neuron on or off. The protein is channelrhodopsin, a gate in the algal cell membrane that opens when struck by light. Hegemann and Nagel identified the protein's light-gating behavior; Deisseroth, working at Stanford, figured out how to put that algal switch into mammalian neurons and use it as a precise control for identified cells in a living brain, according to his Nobel fact sheet.

Deisseroth's breakthrough was published in 2005, and the method was demonstrated in a living mouse brain two years later. From there, it spread through neuroscience as the standard way to ask causal questions about what specific circuits do, on millisecond timescales, in behaving animals.

"This technology is now being used in laboratories around the world to reveal the brain's mysteries," the Nobel committee said, as carried by the AP via KSMU. The committee described the three laureates as having "laid the foundation of a new era in neuroscience," per the Nobel summary.

The 2026 prize lands on a method that is two decades into its working life and is now considered standard in neuroscience. By recognizing optogenetics now, the committee is closing a chapter. The next decade of brain research gets to be built on top of a stable switch rather than waiting for the switch to exist.

The laureates span three institutions on two continents. Hegemann, born in Münster in 1954, holds the chair for experimental biophysics at Humboldt University of Berlin, per his fact sheet. Nagel, born in Weingarten in 1953, is at the University of Würzburg, per his fact sheet. The trio shares the 12 million Swedish kronor prize, about $1.2 million, in equal thirds.

The limits of the tool are real and should be named. Light-based control requires genetic modification of the target cells, which keeps optogenetics in the research category rather than the clinic. Reaching deep tissue means implanting a fiber, because visible light scatters. The method tells you what a circuit can do, not what the brain is doing in a given moment.

The prize rewards a specific capability. Researchers can flip a single identified neuron, in a living brain, on millisecond timescales, with a pulse of light, and watch what changes. No other neuroscience tool offers that resolution of causal control. The 2025 Nobel in medicine went to three scientists for immune-system work. On Tuesday the physics prize is announced, with chemistry, literature, peace, and economics to follow through 12 October.

The switch exists. The field is already using it. The Nobel is the receipt.